Ipsen announces late-breaking data from first head-to-head study comparing Dysport® and Botox® in adults with upper limb spasticity

Keyword: Botulinum Toxin

Publisher: GlobeNewswire

Published: May 19, 2026

Phase IV head-to-head, double-blind trial comparing safety and efficacy met its primary and secondary endpointsThe DIRECTION trial results show the safety profile for Dysport® (abobo… [+11277 chars]

Read Full Story ↗